{"pre_text": ["notes to consolidated financial statements 2014 ( continued ) becton , dickinson and company ( b ) these reclassifications were recorded to interest expense and cost of products sold .", "additional details regarding the company's cash flow hedges are provided in note 13 .", "on august 25 , 2016 , in anticipation of proceeds to be received from the divestiture of the respiratory solutions business in the first quarter of fiscal year 2017 , the company entered into an accelerated share repurchase ( \"asr\" ) agreement .", "subsequent to the end of the company's fiscal year 2016 and as per the terms of the asr agreement , the company received approximately 1.3 million shares of its common stock , which was recorded as a $ 220 million increase to common stock in treasury .", "note 4 2014 earnings per share the weighted average common shares used in the computations of basic and diluted earnings per share ( shares in thousands ) for the years ended september 30 were as follows: ."], "post_text": ["average common and common equivalent shares outstanding 2014 assuming dilution 217536 207509 197709 upon closing the acquisition of carefusion corporation ( 201ccarefusion 201d ) on march 17 , 2015 , the company issued approximately 15.9 million of its common shares as part of the purchase consideration .", "additional disclosures regarding this acquisition are provided in note 9 .", "options to purchase shares of common stock are excluded from the calculation of diluted earnings per share when their inclusion would have an anti-dilutive effect on the calculation .", "for the years ended september 30 , 2016 , 2015 and 2014 there were no options to purchase shares of common stock which were excluded from the diluted earnings per share calculation. ."], "table": [["", "2016", "2015", "2014"], ["average common shares outstanding", "212702", "202537", "193299"], ["dilutive share equivalents from share-based plans", "4834", "4972", "4410"], ["average common and common equivalent shares outstanding 2014 assuming dilution", "217536", "207509", "197709"]], "table_ori": [["", "2016", "2015", "2014"], ["Average common shares outstanding", "212,702", "202,537", "193,299"], ["Dilutive share equivalents from share-based plans", "4,834", "4,972", "4,410"], ["Average common and common equivalent shares outstanding — assuming dilution", "217,536", "207,509", "197,709"]]}

Question: as of september 30 ,2014 what was the percent of the total average common and common equivalent shares outstanding 2014 assuming dilution that was dilute share equivalents from share-based plans
Evidence:
table_2: the dilutive share equivalents from share-based plans of 2016 is 4834 ; the dilutive share equivalents from share-based plans of 2015 is 4972 ; the dilutive share equivalents from share-based plans of 2014 is 4410 ;
table_3: the average common and common equivalent shares outstanding 2014 assuming dilution of 2016 is 217536 ; the average common and common equivalent shares outstanding 2014 assuming dilution of 2015 is 207509 ; the average common and common equivalent shares outstanding 2014 assuming dilution of 2014 is 197709 ;
Program: divide(4410, 197709)
Answer:
str_answer: 2.23%
exe_answer: 0.02231